scholarly journals Characterization of Lipid Profiles after Dietary Intake of Polyunsaturated Fatty Acids Using Integrated Untargeted and Targeted Lipidomics

Metabolites ◽  
2019 ◽  
Vol 9 (10) ◽  
pp. 241 ◽  
Author(s):  
Satoko Naoe ◽  
Hiroshi Tsugawa ◽  
Mikiko Takahashi ◽  
Kazutaka Ikeda ◽  
Makoto Arita
Keyword(s):  
Fatty Acids ◽  
Lipid Metabolism ◽  
Polyunsaturated Fatty Acids ◽  
Dietary Intake ◽  
Lipid Profiles ◽  
Pufa Supplementation ◽  
Nutrition Research ◽  
Mouse Tissues ◽  
Living Organisms

Illuminating the comprehensive lipid profiles after dietary supplementation of polyunsaturated fatty acids (PUFAs) is crucial to revealing the tissue distribution of PUFAs in living organisms, as well as to providing novel insights into lipid metabolism. Here, we performed lipidomic analyses on mouse plasma and nine tissues, including the liver, kidney, brain, white adipose, heart, lung, small intestine, skeletal muscle, and spleen, with the dietary intake conditions of arachidonic acid (ARA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) as the ethyl ester form. We incorporated targeted and untargeted approaches for profiling oxylipins and complex lipids such as glycerol (phospho) lipids, sphingolipids, and sterols, respectively, which led to the characterization of 1026 lipid molecules from the mouse tissues. The lipidomic analysis indicated that the intake of PUFAs strongly impacted the lipid profiles of metabolic organs such as the liver and kidney, while causing less impact on the brain. Moreover, we revealed a unique lipid modulation in most tissues, where phospholipids containing linoleic acid were significantly decreased in mice on the ARA-supplemented diet, and bis(monoacylglycero)phosphate (BMP) selectively incorporated DHA over ARA and EPA. We comprehensively studied the lipid profiles after dietary intake of PUFAs, which gives insight into lipid metabolism and nutrition research on PUFA supplementation.

The Associations of Dietary Intake of Polyunsaturated Fatty Acids With Diabetic Retinopathy in Well-Controlled Diabetes

2015 ◽  
Vol 56 (12) ◽  
pp. 7473 ◽  
Author(s):  
Mariko Sasaki ◽  
Ryo Kawasaki ◽  
Sophie Rogers ◽  
Ryan Eyn Kidd Man ◽  
Katsumasa Itakura ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Diabetic Retinopathy ◽  
Polyunsaturated Fatty Acids ◽  
Dietary Intake

scholarly journals Modulation of Systemic and Aortic Nitric Oxide by Melatonin and n-3 Polyunsaturated Fatty Acids in Isoproterenol Affected Spontaneously Hypertensive and Normotensive Wistar Rats

2016 ◽  
pp. S109-S118 ◽  
Author(s):  
K. K. CHAUDAGAR ◽  
C. VICZENCZOVA ◽  
B. SZEIFFOVA BACOVA ◽  
T. EGAN BENOVA ◽  
M. BARANCIK ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Fatty Acids ◽  
Polyunsaturated Fatty Acids ◽  
Wistar Rats ◽  
Dependent Manner ◽  
Pufa Supplementation ◽  
Pufa Intake ◽  
Spontaneously Hypertensive ◽  
No Release ◽  
Strain Dependent

We aimed to explore the effects of melatonin and n-3 polyunsaturated fatty acids (PUFA) supplementation on plasma and aortic nitric oxide (NO) levels in isoproterenol (Iso) affected spontaneously hypertensive (SHR) and Wistar rats. Untreated control rats were compared with Iso injected (118 mg/kg, s.c.) rats, and Iso injected plus supplemented with melatonin (10 mg/kg, p.o.) or PUFA (1.68 g/kg, p.o.) for two months. Plasma and aortic basal, L-NAME inhibited, adrenaline and acetylcholine stimulated NO were determined using Griess method. Plasma NO levels were lower in SHR versus Wistar rats. Iso decreased NO in Wistar while not in SHR. PUFA but not melatonin intake of Iso treated SHR increased plasma NO along with a decrease in systolic blood pressure. Basal aortic NO level was higher in SHR than Wistar rats and not altered by Iso. Intake of melatonin increased but PUFA decreased basal NO levels in Wistar+Iso and did not affect in SHR+Iso rats. Acetylcholine and adrenaline induced aortic NO release was significantly increased in Wistar+Iso but not SHR+Iso group. Melatonin intake increased Ach induced aortic NO in Wistar+Iso and SHR+Iso groups, whereas there was no effect of PUFA intake. Findings suggest that PUFA modulates plasma and melatonin aortic NO levels of isoproterenol affected rats in a strain-dependent manner.

scholarly journals Polyunsaturated fatty acids in the treatment of attention deficit hyperactivity disorder

2014 ◽  
Vol 4 (6) ◽  
pp. 245 ◽  
Author(s):  
Klaus W. Lange ◽  
Joachim Hauser ◽  
Shigehiko Kanaya ◽  
Ivo Kaunzinger ◽  
Katharina M Lange ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Attention Deficit Hyperactivity Disorder ◽  
Polyunsaturated Fatty Acids ◽  
Attention Deficit ◽  
Adhd Symptoms ◽  
Omega 3 ◽  
Dietary Pufa ◽  
Blood Concentrations ◽  
Pufa Supplementation ◽  
Hyperactivity Disorder

Background: Attention deficit/hyperactivity disorder (ADHD) is one of the most common behavioral disorders in children. Insufficient dietary intake of long-chain polyunsaturated fatty acids (LC-PUFAs) has been suggested to have an impact on the development of symptoms of ADHD in children. Individuals with ADHD have been demonstrated to have significantly reduced blood concentrations of PUFAs and, in particular, reduced levels of omega-3 (n-3) PUFAs. These findings suggest that PUFA supplementation may reduce the attention and behavior problems associated with ADHD.Objective: To provide an overview of the efficacy of dietary LC-PUFA supplementation in the treatment of ADHD. Methods: Literature published up until December 2013 on the effects of n-3 PUFA supplementation on ADHD symptoms was obtained using a PubMed search and critically reviewed.Results: Dietary PUFA supplementation appears to have beneficial effects on ADHD symptoms although these effects are small. The clinical relevance of these observations remains to be determined.Conclusion: There is only limited support for the efficacy of PUFA supplementation for the core symptoms of ADHD. Given the small effect sizes regarding PUFA supplementation, it may not be a sufficient therapy for a majority of patients with ADHD.Keywords: diet, nutrition, polyunsaturated fatty acid, PUFA, attention deficit/hyperactivity disorder, ADHD

scholarly journals Positive Associations of Dietary Marine Omega-3 Polyunsaturated Fatty Acids with Lung Function: A Meta-analysis (P18-087-19)

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Bonnie Patchen ◽  
Jiayi Xu ◽  
R Graham Barr ◽  
Ester van Eekelen ◽  
Josee Dupuis ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Lung Function ◽  
Polyunsaturated Fatty Acids ◽  
Dietary Intake ◽  
Fixed Effects ◽  
Meta Analysis ◽  
Fish Intake ◽  
Omega 3 ◽  
Black And White ◽  
Former Smokers

Abstract Objectives Our previous study found positive associations between plasma levels of the omega-3 polyunsaturated fatty acids (n-3 PUFAs), specifically docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA), and lung function, especially in current smokers. Given that plasma n-3 PUFA concentrations are driven by dietary intake, we extended our prior findings to a larger sample by studying dietary n-3 PUFAs, including DHA, DPA, eicosapentanoic acid (EPA), and alpha-linolenic acid (ALA), and fish intake. Methods Nine cohorts from the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (N = 37,077 black and white participants) contributed dietary intake and lung function data. In each cohort and each ancestry, separately, associations of dietary n-3 PUFA/fish intake with lung function were estimated in linear regression models. Models were extended to test for n-3 PUFA/fish × smoking status interaction. Fixed-effects meta-analysis was used to generate summarized effect estimates across the cohorts and ancestries. Results Dietary DPA, DHA, EPA, and fish intake were positively associated with forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). ALA had little to no association with these lung function parameters. Associations were similar for black and white participants, and consistent in direction and magnitude across most cohorts. For all participants, 1 standard deviation (SD) higher intake of DPA (∼30 mg/d), DHA (∼200 mg/d), and EPA (∼150 mg/d) were associated with 12–16 mL higher FEV1 and 10–15 mL higher FVC. The effect estimates for fish were in the same direction but smaller in magnitude. Smoking modified the associations of DHA and EPA with FEV1 and FVC; 1 SD higher intake of DHA and EPA were associated with 28–32 mL higher FEV1 and 24–25 mL higher FVC in current smokers, 17–21 mL higher FEV1 and 7–12 mL higher FVC in former smokers, and little to no association in never smokers. Conclusions Dietary DHA, DPA, and EPA, but not ALA, are positively associated with FEV1 and FVC, corroborating our previous findings for plasma n-3 PUFAs. This large cross-sectional meta-analysis shows that diets rich in marine n-3 PUFAs are associated with higher lung function, especially for current and former smokers. Funding Sources National Institutes of Health, NHLBI and NIDDK.

Sign in / Sign up

Export Citation Format

Share Document